|
|
||||||||
RESEARCH REPORT |
Department of Periodontology, Division of Oral Biology and Disease Control, Osaka University Graduate School of Dentistry, 1-8 Yamadaoka Suita, Osaka 565-0871, Japan;
* corresponding author, ipshinya{at}dent.osaka-u.ac.jp
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: T-lymphocyte gingival fibroblast adhesive interaction CD13
| INTRODUCTION |
|---|
|
|
|---|
CD13 (aminopeptidase N) is a 150-kDa membrane alanyl metallopeptidase found on a variety of cells that is able to split amino acids from the N-terminus, with the exception of proline in the penultimate position (Hanson et al., 1967). Thus, CD13 on leukocytes is supposed to be involved in the degradation of neuropeptides (Giros et al., 1986; Furuhashi et al., 1988; Shimamura et al., 1991; Ahmad et al., 1992) and cytokines (Hoffmann et al., 1993; Kanayama et al., 1995), though its functions remain to be fully elucidated. CD13 has also been implicated in the Ag processing of peptides bound in the groove of MHC class II molecules (Hansen et al., 1993; Larsen et al., 1996), and is known to be involved in the regulation of lymphocyte activation and immune response (Ansorge et al., 1991). Although lymphocytes in peripheral blood do not express CD13, CD13-positive T-lymphocytes have been observed in chronic inflammatory sites (Riemann et al., 1993, 1994), and the possible involvement of stromal cell adherence in the induction of CD13 expression on T-lymphocytes has been suggested (Riemann et al., 1997). In the present study, we examined whether lymphocyte-HGF interaction can activate not only HGF but also T-lymphocytes to express CD13. Furthermore, we confirmed the presence of CD13-positive T-lymphocytes in periodontal lesions in vivo.
| MATERIALS & METHODS |
|---|
|
|
|---|
Purification of Peripheral Blood T-lymphocytes
Peripheral blood T-lymphocytes (PBT) were isolated from healthy donors as previously described (Murakami et al., 1993a). The purified PBT utilized in this study contained more than 95% CD3-positive cells.
Antibodies
Mouse monoclonal antibody (mAb) 22A5 (anti-CD13)-biotin conjugate was purchased from Leinco Technologies (Ballwin, MO, USA). Mouse mAb UCHT1 (anti-CD3) labeled with fluorescein isothiocyanate (FITC) was purchased from Pharmingen (San Diego, CA, USA).
Co-culture of PBT with HGF
PBT (1.5 x 106/dish) were cultured in the presence or absence of 0.5 µg/mL phorbol 12-myristate 13-acetate (PMA) for 24 hrs and then added to six-well plates (no. 3516, Corning Inc., Corning, NY, USA) containing a confluent HGF monolayer. In some experiments, the requirement of direct interaction between PBT and HGF was examined by the use of cylindrical wells in which collagen-treated microporous membranes were assembled as previously described (Murakami et al., 1999). The plates were then incubated for the indicated period at 37°C. After the co-culture, PBT were harvested and utilized for the experiments.
RT-PCR Analysis
Total RNA and cDNA were prepared and PCR were performed according to the method of Yanagita et al.(2002). Oligonucleotide PCR primers specific for CD13 and hypoxanthine phosphoribosyl transferase (HPRT) were synthesized at Takara Shuzo Co. Ltd. (Kyoto, Japan). The primers for CD13 were: (sense) 5'-GTC TAC TGC AAC GCT ATC GC-3' and (antisense) 5'-GAT GGA CAC ATG TGG GCA CCT TG-3'. Those for HPRT were: (sense) 5'-CGA GAT GTG ATG AAG GAG ATG GG-3' and (antisense) 5'-GCC TGA CCA AGG AAA GCA AAG TC-3'.
Isolation of Mononuclear Cells from Gingival Tissues
Gingival tissues were obtained from periodontal biopsies taken from periodontitis patients. The gingival tissues were minced and washed extensively in phosphate-buffered saline (PBS), after which infiltrated cells were obtained by the use of an automated disaggregation machine (Medimachine, DAKO, Glostrup, Denmark) according to the manufacturers instructions. The harvested cells were washed with HBSS (Sigma Chemical Co., St. Louis, MO, USA) and transferred to RPMI 1640 (Sigma Chemical Co.) supplemented with 10% FCS (HyClone Sterile System, Logan, VT, USA). Mononuclear cells were then isolated by gradient centrifugation on a histopaque gradient (density 1.077 g/mL, Sigma Diagnostic, St. Louis, MO, USA). The whole isolation process described above was performed in 1.5 hrs at 4°C.
Surface Expression and Enzyme Activity of CD13
Cell suspensions were prepared in PBS without phenol red containing 1% BSA and 0.1% sodium azide, and 1 x 106 cells were incubated for 30 min at 4°C with biotin-conjugated 22A5 mAb followed by phycoerythrin (PE)-conjugated streptavidin (SAv) (Pharmingen). In some experiments, single cell suspensions (1 x 106) from gingival tissues were incubated for 30 min at 4°C with FITC-conjugated UCHT1 mAb and/or biotin-conjugated 22A5 mAb, followed by PE-conjugated SAv. After incubation, the cells were washed twice, re-suspended, and analyzed for fluorescence.
To examine CD13 enzyme activity, we prepared cell suspensions of PBT in 50 µL of PBS and incubated 1.5 x 105 cells for 510 min at 37°C in a water bath. The enzyme substrate [non-fluorescent Di-(Alanyl)-Rhodamine 110 conjugate] (CellProbe Reagent; Coulter Co., Miami, FL, USA) was then added to each cell sample according to the manufacturers instructions. In some experiments, PBT were pre-treated for 1 hr with Bestatin (Sigma Chemical Co.), CD13-specific inhibitor. After incubation, samples were placed on ice for 320 min and suspended in 1 mL of PBS. Prepared samples were immediately placed on ice until analysis for fluorescence. Flow cytometric analyses were performed with the use of a FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA, USA).
Immunohistochemical Staining
Human gingival tissue specimens were obtained from patients during periodontal surgery. For fixation of gingival tissue specimens, the specimens were fixed with 4% paraformaldehyde in PBS (pH 7.4) for 3 days, immersed overnight in 2% sucrose in PBS at 4°C, and embedded in OCT compound (Lab-TEK, Naperville, IL, USA), quickly frozen in liquid nitrogen. Serial sections (8 µm thick) were cut and put onto silanized glass slides (Nalge Nunc International Corp., Naperville, IL, USA). The tissue samples were incubated overnight at room temperature with FITC-conjugated UCHT1 mAb and biotin-conjugated 22A5 mAb, followed by PE-conjugated SAv. After incubation, the tissue samples were washed with distilled water, included with PermaFluor (Immunon, Pittsburgh, PA, USA), and analyzed for fluorescence with Axioskop 2 plus (Carl Zeiss, Göttingen, Germany).
Statistical Analysis
To test the statistical significance of the CD13-positive ratio between T-lymphocytes that had infiltrated gingival tissues and freshly isolated PBT, we compared data using Students t test.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Interestingly, it was demonstrated that direct interaction between lymphocytes and HGF stimulated inflammatory cytokine mRNA expression in the HGF (Murakami et al., 1999) and that the lymphocytes were prevented from dying and leaving inflamed tissue by an inappropriate expression of pro-survival chemokines (IFN-ß) and pro-retention chemokines (SDF-1) by fibroblasts within the chronically inflamed tissue (Buckley et al., 2001). In the present study, we demonstrated that cognate-type interactions between HGF and PBT stimulated the PBT to induce CD13 expression on their surfaces. These results suggest that the adhesive interactions between lymphocytes and HGF have a mutual influence on the functional activities of each cell type (Murakami and Okada, 1997; Murakami et al., 1997).
In the present study, CD13 was detected on the cell surfaces of locally infiltrated T-lymphocytes in inflamed gingival tissues, but not on those of PBT isolated from the same donors (Fig. 4A
). This strongly suggests that locally infiltrated T-lymphocytes have an opportunity to interact directly with neighboring HGF. Likewise, Riemann et al.(1993) examined CD13 surface expression on T-lymphocytes in synovial fluid and peripheral blood from patients suffering from juvenile chronic arthritis or rheumatoid arthritis, and reported that CD13 expression in T-lymphocytes was found only in synovial fluid from patients with chronic arthritis. Those and our results suggest that CD13-positive T-lymphocytes play some role in the formation of locally chronic inflammatory diseases.
With regard to the function of CD13, lymphocytic expression of CD13 represents a potentially increased cellular ability to inactivate inflammatory mediators. Furthermore, CD13 may be involved in degradation of the extracellular matrix during lymphocytic migration. As for T-lymphocytes, it was reported that the CD13 inhibitors probestin and actinonin reduced the proliferation of a CD13-positive T-cell line, KARPAS-299. Moreover, a study aimed at the identification of potential targets that mediate the anti-proliferative effects of CD13 expression and activity revealed a modulation of MAP kinase p42/Erk2 activity and mRNA levels in the same human T-cell line by probestin and actinonin (Lendeckel et al., 1998). This suggests that the enzyme activity of CD13 on T-lymphocytes may be related to proliferative responses of the T-lymphocytes. Recently, Mishima et al.(2002) indicated that the high level of CD13 expression on the surfaces of lymphoid cells could be important for their survival. Interestingly, we also found that T-lymphocytes survived over a long period of time when the cells were co-cultured with HGF (data not shown). Another important function of CD13 is to play a role in antigen processing by the trimming of peptides on the cell surface that protrude from MHC class II molecules. We found that the cell-surface expression of MHC class II molecules was also induced on PMA-stimulated PBT upon adhesion to HGF (data not shown). Taken together, these findings suggest that locally infiltrated T-lymphocytes express CD13 on the cell surface through direct adherence with HGF and survive over a long period of time, while locally infiltrated CD13-positive T-lymphocytes may act as effective antigen-presenting cells in inflamed gingival tissues.
The present findingsthat direct interactions with HGF are essential for the induction of CD13 expression on PBT in vitro, and that CD13 is expressed on the cell surfaces of locally infiltrated T-lymphocytes in gingival tissues in vivostrongly suggest that T-lymphocytes can be activated through direct adhesion with HGF in chronic periodontal lesions. Additional studies to examine the pathophysiological roles of CD13-positive T-lymphocytes will be necessary for a better understanding of the immunopathogenesis of periodontitis.
| ACKNOWLEDGMENTS |
|---|
Received February 21, 2003; Last revision August 11, 2003; Accepted August 27, 2003
| REFERENCES |
|---|
|
|
|---|
Ansorge S, Schon E, Kunz D (1991). Membrane-bound peptidases of lymphocytes: functional implications. Biomed Biochim Acta 50:799807.[ISI][Medline]
Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M (2001). Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 22:199204.[ISI][Medline]
Furuhashi M, Mizutani S, Kurauchi O, Kasugai M, Narita O, Tomoda Y (1988). In vitro degradation of opioid peptides by human placental aminopeptidase M. Exp Clin Endocrinol 92:235237.[ISI][Medline]
Giros B, Gros C, Solhonne B, Schwartz JC (1986). Characterization of amino-peptidases responsible for inactivating endogenous (Met5) enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies. Mol Pharmacol 29:281287.[Abstract]
Hansen AS, Noren O, Sjostrom H, Werdelin O (1993). A mouse aminopeptidase N is a marker for antigen-presenting cells and appears to be co-expressed with major histocompatibility complex class II molecules. Eur J Immunol 13:23582364.
Hanson H, Hutter HJ, Mannsfeldt H, Kretschmer K, Sohr C (1967). On the demonstration and substrate specificity of a kidney particle aminopeptidase distinguishable from leucine aminopeptidase. Hoppe Seylers Z Physiol Chem 348:680688.[ISI][Medline]
Hoffmann T, Faust J, Neubert K, Ansorge S (1993). Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences. FEBS Lett 336:6164.[ISI][Medline]
Kanayama N, Kajiwara Y, Goto J, el Maradny E, Maehara K, Andou K, et al. (1995). Inactivation of interleukin-8 by aminopeptidase N (CD13). J Leukoc Biol 57:129134.[Abstract]
Larsen SL, Pedersen LO, Buus S, Stryhn A (1996). T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides. J Exp Med 184:183189.
Lendeckel U, Kahne T, Arndt M, Frank K, Ansorge S (1998). Inhibition of alanyl aminopeptidase induces MAP-kinase p42/ERK2 in the human T cell line KARPAS-299. Biochem Biophys Res Commun 252:59.
Mishima Y, Matsumoto-Mishima Y, Terui Y, Katsuyama M, Yamada M, Mori M, et al. (2002). Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells. J Natl Cancer Inst 94:10201028.
Murakami S, Okada H (1997). Lymphocyte-fibroblast interactions. Crit Rev Oral Biol Med 8:4050.
Murakami S, Saho T, Shimabukuro Y, Isoda R, Miki Y, Okada H (1993a). Very late antigen integrins are involved in the adhesive interaction of lymphoid cells to human gingival fibroblasts. Immunology 79:425433.[ISI][Medline]
Murakami S, Shimabukuro Y, Saho T, Isoda R, Kameyama K, Yamashita K, et al. (1993b). Evidence for a role of VLA integrins in lymphocyte-human gingival fibroblast adherence. J Periodontal Res 28:494496.[ISI][Medline]
Murakami S, Shimabukuro Y, Miki Y, Saho T, Hino E, Kasai D, et al. (1994). Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis. J Immunol 152:467477.[Abstract]
Murakami S, Saho T, Asari A, Hino E, Kasai D, Shimabukuro Y, et al. (1996). CD44-hyaluronate interaction participates in the adherence of T-lymphocytes to gingival fibroblasts. J Dent Res 75:15451552.
Murakami S, Shimabukuro Y, Saho T, Hino E, Kasai D, Hashikawa T, et al. (1997). Immunoregulatory roles of adhesive interactions between lymphocytes and gingival fibroblasts. J Periodontal Res 32:110114.[ISI][Medline]
Murakami S, Hino E, Shimabukuro Y, Nozaki T, Kusumoto Y, Saho T, et al. (1999). Direct interaction between gingival fibroblasts and lymphoid cells induces inflammatory cytokine mRNA expression in gingival fibroblasts. J Dent Res 78:6976.
Okada H, Kida T, Yamagami H (1983). Identification and distribution of immunocompetent cells in inflamed gingiva of human chronic periodontitis. Infect Immun 41:365374.
Riemann D, Schwachula A, Hentschel M, Langner J (1993). Demonstration of CD13/aminopeptidase N on synovial fluid T cells from patients with different forms of joint effusions. Immunobiology 187:2435.[ISI][Medline]
Riemann D, Wollert HG, Menschikowski J, Mittenzwei S, Langner J (1994). Immunophenotype of lymphocytes in pericardial fluid from patients with different forms of heart disease. Int Arch Allergy Immunol 104:4856.[ISI][Medline]
Riemann D, Kehlen A, Thiele K, Lohn M, Langner J (1997). Induction of aminopeptidase N/CD13 on human lymphocytes after adhesion to fibroblast-like synoviocytes, endothelial cells, epithelial cells, and monocytes/macrophages. J Immunol 158:34253432.[Abstract]
Schroeder HE, Page R (1972). Lymphocyte-fibroblast interaction in the pathogenesis of inflammatory gingival disease. Experientia 28:12281230.[ISI][Medline]
Shimamura M, Hazato T, Iwaguchi T (1991). Enkephalin-degrading aminopeptidase in the longitudinal muscle layer of guinea pig small intestine: its properties and action on neuropeptides. J Biochem Tokyo 109:492497.
Yanagita M, Shimabukuro Y, Nozaki T, Yoshimura N, Watanabe J, Koide H, et al. (2002). IL-15 up-regulates iNOS expression and NO production by gingival epithelial cells. Biochem Biophys Res Commun 297:329334.[ISI][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |